Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual
- 1 May 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (9) , 1351-1360
- https://doi.org/10.1016/0006-2952(91)90108-h
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Randomized clinical trial of mitomycin c as an adjunct to radiotherapy in head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditionsBritish Journal of Cancer, 1989
- Modulation of the antineoplastic efficacy of mitomycin C by dicoumarol in vivoCancer Chemotherapy and Pharmacology, 1989
- Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation dennisInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin CAdvances in Enzyme Regulation, 1985
- Rat liver DT-diaphorase: Regulation of functional mRNA levels by 3-methylcholanthrene, trans-stilbene oxide, and phenobarbitalArchives of Biochemistry and Biophysics, 1984
- Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell LinesScience, 1983
- Metabolic activation of mitomycin C by liver microsomes and nucleiBiochemical Pharmacology, 1982
- [7] Purification and properties of NADPH-Cytochrome P-450 reductasePublished by Elsevier ,1978
- [56] DT diaphorasePublished by Elsevier ,1967